Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease

Detalles Bibliográficos
Autores principales: Li, Ting, Gu, Liyang, Wang, Xiaodong, Guo, Li, Shi, Hui, Yang, Chengde, Chen, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Publisher Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281664/
https://www.ncbi.nlm.nih.gov/pubmed/30518948
http://dx.doi.org/10.1038/s41598-018-36662-z
_version_ 1783378859989663744
author Li, Ting
Gu, Liyang
Wang, Xiaodong
Guo, Li
Shi, Hui
Yang, Chengde
Chen, Sheng
author_facet Li, Ting
Gu, Liyang
Wang, Xiaodong
Guo, Li
Shi, Hui
Yang, Chengde
Chen, Sheng
author_sort Li, Ting
collection PubMed
description
format Online
Article
Text
id pubmed-6281664
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-62816642018-12-07 Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease Li, Ting Gu, Liyang Wang, Xiaodong Guo, Li Shi, Hui Yang, Chengde Chen, Sheng Sci Rep Publisher Correction Nature Publishing Group UK 2018-12-05 /pmc/articles/PMC6281664/ /pubmed/30518948 http://dx.doi.org/10.1038/s41598-018-36662-z Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Publisher Correction
Li, Ting
Gu, Liyang
Wang, Xiaodong
Guo, Li
Shi, Hui
Yang, Chengde
Chen, Sheng
Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
title Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
title_full Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
title_fullStr Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
title_full_unstemmed Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
title_short Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
title_sort publisher correction: a pilot study on tocilizumab for treating refractory adult-onset still’s disease
topic Publisher Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281664/
https://www.ncbi.nlm.nih.gov/pubmed/30518948
http://dx.doi.org/10.1038/s41598-018-36662-z
work_keys_str_mv AT liting publishercorrectionapilotstudyontocilizumabfortreatingrefractoryadultonsetstillsdisease
AT guliyang publishercorrectionapilotstudyontocilizumabfortreatingrefractoryadultonsetstillsdisease
AT wangxiaodong publishercorrectionapilotstudyontocilizumabfortreatingrefractoryadultonsetstillsdisease
AT guoli publishercorrectionapilotstudyontocilizumabfortreatingrefractoryadultonsetstillsdisease
AT shihui publishercorrectionapilotstudyontocilizumabfortreatingrefractoryadultonsetstillsdisease
AT yangchengde publishercorrectionapilotstudyontocilizumabfortreatingrefractoryadultonsetstillsdisease
AT chensheng publishercorrectionapilotstudyontocilizumabfortreatingrefractoryadultonsetstillsdisease

Ejemplares similares